| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement
|
|
|
2015
|
64 |
4 |
p. 527-530
|
artikel
|
| 2 |
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)
|
Lacouture, Mario E.
|
|
2015
|
64 |
4 |
p. 437-446
|
artikel
|
| 3 |
DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma
|
Wu, Ming-Ru
|
|
2014
|
64 |
4 |
p. 409-418
|
artikel
|
| 4 |
Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide
|
Morin-Brureau, Mélanie
|
|
2015
|
64 |
4 |
p. 447-457
|
artikel
|
| 5 |
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
|
Sayour, Elias J.
|
|
2014
|
64 |
4 |
p. 419-427
|
artikel
|
| 6 |
Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice
|
Ito, Hiroyasu
|
|
2015
|
64 |
4 |
p. 429-436
|
artikel
|
| 7 |
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence
|
Okroj, Marcin
|
|
2015
|
64 |
4 |
p. 467-478
|
artikel
|
| 8 |
Low-dose cyclophosphamide enhances antigen-specific CD4+ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
|
Klein, Oliver
|
|
2015
|
64 |
4 |
p. 507-518
|
artikel
|
| 9 |
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
|
Noguchi, Masanori
|
|
2015
|
64 |
4 |
p. 493-505
|
artikel
|
| 10 |
Prostate cancer vaccines: the long road to clinical application
|
Baxevanis, Constantin N.
|
|
2015
|
64 |
4 |
p. 401-408
|
artikel
|
| 11 |
Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination
|
Quiroga, Dionisia
|
|
2015
|
64 |
4 |
p. 479-491
|
artikel
|
| 12 |
Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination
|
Quiroga, Dionisia
|
|
|
64 |
4 |
p. 479-491
|
artikel
|
| 13 |
The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
|
Hughes, Tasha
|
|
2015
|
64 |
4 |
p. 459-465
|
artikel
|
| 14 |
“Tumor immunology meets oncology” (TIMO) X, May 23–24, 2014, Halle/Saale, Germany
|
Quandt, Dagmar
|
|
2015
|
64 |
4 |
p. 519-526
|
artikel
|
Tijdschrift beschrijving